Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BLUECELL BIO ApS
APS
Active
CVR 45783669
Amalievej 20
Manufacture of homogenised food preparations and dietetic food · NACE 1086
Est. 2025
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK -335K
EBITDA margin
127.1%
Equity ratio
91.3%
Financial strength
Net profit 2025
DKK -426K
2 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2025
Key figures
Annual report 2025
Revenue
DKK -335K
—
EBITDA
DKK -426K
—
Net profit
DKK -426K
—
Total assets
DKK 1,2M
—
Equity
DKK 1,1M
—
Employees
2
—
Company information
Legal name
BLUECELL BIO ApS
CVR number
45783669
Legal form
Anpartsselskab
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
14. juli 2025
Share capital
DKK 55.740
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at udvikle og kommercialisere teknologier til produktion af fødevarer og/eller foderprodukter gennem bioteknologi.
Contact
Address
Amalievej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of homogenised food preparations and dietetic food
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
DKK thousands
Item
2025
Revenue
-335
Staff expenses
-91
EBITDA
-426
Depreciation & amort.
-0
EBIT
-426
Net financials
-0
Profit before tax
-426
Tax
-0
Net profit
-426
Balance sheet
DKK thousands
Item
2025
Total assets
1.209
Equity
1.104
Long-term debt
0
Short-term debt
105
Total debt
105
Financial ratios
5-year trend
EBITDA margin
-42596500.0%
This company
15.8%
Market median
-269598201% vs market
2025
2025
Equity ratio
91.3%
This company
38.2%
Market median
+139% vs market
2025
2025
Return on equity
-38.6%
This company
18.4%
Market median
-310% vs market
2025
2025
Net profit margin
-42597700.0%
This company
8.1%
Market median
-525897631% vs market
2025
2025
Asset turnover
-0.28×
This company
1.12×
Market median
-125% vs market
2025
2025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-07-14 – 2025-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
CE
Carl Edvard Georg Hall
Chief Executive Officer
Chief Executive Officer
2025
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Könyves Invest AB
Individual
50.0%
50.0%
2025
Kost Capital Fund I K/S
Company
25.0%
25.0%
2025
Kost Studio ApS
Company
5.0%
5.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BECK'S PLAYGROUND ApS
Kost Studio ApS
BLUECELL BIO ApS
(this company)
Board network connections
Board members of BLUECELL BIO ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Carl Edvard Georg Hall
Chief Executive Officer
0 companies